Skip to main content
. 2015 Jan 23;9(4):312–317. doi: 10.1093/ecco-jcc/jjv027

Table 2.

Number of adverse events of MTX per treatment modality in 13 patients.

Event type Low [≤12.5mg] High [15-25mg] Total:
Oral Injection Oral Injection
Increased ALT/AST > x 2 1 1 2 4
Nausea ± vomiting 3 1 2 6
Fatigue 1 1
Low-grade fever 1 1
Headache 1 1 2
General malaise 1 1
Rash 1 1
Joint pain 1 1
Total events: 6 1 4 6 17

MTX, methotrexate; ALT, alanine aminotransferase; AST; aspartate aminotransferase.